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Abstract
The initial step of mucin-type O-glycosylation is catalyzed by UDP-GalNAc: polypep-
tide N-acetylgalactosaminyltransferases (GalNAc-transferases). GalNAc-transferases contain
a lectin domain at the C-terminus, consisting of three tandem repeats (α, β, and γ). I have
reevaluated the role of the GalNAc-T1 lectin domain in this study, because the putative lectin
domain of this enzyme is reportedly not functional. Deletion of the lectin domain resulted in a
complete loss of enzymatic activity. I found that GalNAc-T1 has two activities distinguished
by their sensitivities to inhibition with free GalNAc; one activity is sensitive, the other is
resistant. In my experiments, the former activity is represented by the O-glycosylation of
apomucin, an acceptor that contains multiple glycosylation sites, and the latter by synthetic
peptides that contain a single glycosylation site. Site-directed mutagenesis of the lectin do-
main selectively reduced the follow-up activity, and identified Asp444 in the α repeat as the
most important site for GalNAc recognition. I also found that the β repeat recognizes GalNAc
and is involved in glycosylation of acceptors with multiple glycosylation sites. These results
indicate that the lectin domain of GalNAc-T1 has at least two functional repeats, allowing the
possibility of multivalent interactions with GalNAc residues on the acceptor peptide during
glycosylation.
Keywords: mucin-type O-glycosylation, GalNAc-transferase, lectin domain, structure-
function relationship, site-directed mutagenesis
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1. Introduction
The initial step in the biosynthesis of mucin-type O-glycosylation is catalyzed by a group
of enzymes known as the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferases (EC
2.4.1.41) (GalNAc-transferases). These enzymes transfer GalNAc from the nucleotide-sugar
donor, UDP-GalNAc, to certain serine and threonine residue on acceptor proteins [1–3]. Thus,
GalNAc transferases are regarded as key enzymes in O-glycan biosynthesis because they define
the number and position(s) of mucin carbohydrates on glycoproteins. Recent progress in the
molecular cloning of GalNAc-transferases has revealed a large gene family [4–19]. All cloned
GalNAc-transferases are type II membrane proteins [20] with a common domain structure that
includes a short N-terminal cytoplasmic tail, a transmembrane domain, a stem domain, a pu-
tative catalytic domain, and C-terminal (QXW)3 repeats. The central catalytic domain can be
further subdivided into two regions. The N-terminal half is represented by a glycosyltransferase
1 (GT1) motif that is conserved among a wide range of glycosyltransferases [21]. The extreme
C-terminal end of the GT1 motif contains a so-called DXH motif, which corresponds to the
DXD sequence common to many glycosyltransferases [22]. The C-terminal half of the cat-
alytic domain contains a so-called Gal/GalNAc-T motif, a sequence segment where significant
homology can be seen between β1,4-galactosyltransferases and GalNAc-transferases [21,23].
The C-terminal (QXW)3 repeats occur exclusively in the GalNAc-transferases [24]. This
domain, which consists of three tandem repeats (α, β, and γ) with approximately 50 amino acid
residues in each repeat unit, are homologous to the B-chain in the plant lectin ricin [24]. Hence,
it is assumed that the (QXW)3 repeats of the GalNAc-transferases can function as a lectin, al-
though no direct sugar binding activity has been demonstrated. X-Ray crystallography studies
have revealed distinct features of the ricin molecular structure [25–27]. Each repeat unit in the
molecule has a unique, globular structure with several conserved hydrophobic amino acids at
the core. Moreover, the cysteine residues in the repeats are essential for proper folding, and sev-
eral amino acid residues in the molecule has been shown to interact with the haptenic monosac-
charide, galactose. There is no information available about the three-dimensional structures of
the (QXW)3 repeats in the GalNAc-transferase lectin domains. However, computer-based anal-
ysis predicts conformational similarity with the ricin lectin domain [28,29]. Until recently, the
function of the GalNAc-transferase lectin domain remained largely unknown. However, recent
work has demonstrated the importance of this domain for GalNAc-T4, an isozyme that requires
prior O-glycosylation of the acceptor peptides for catalytic activity [30,31]. In contrast, glyco-
sylation by GalNAc-T1, one of the most ubiquitous isozymes, is considered independent of the
(QXW)3 repeats, since the mutations in this domain resulted in no, or only modest effects on
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the activity [21]. In this study, I have reevaluated the functional role of the GalNAc-T1 lectin
domain, and I demonstrate that this domain is involved in glycosylation of polypeptides with
multiple acceptor sites. Detailed information on the structure-function relationship of the lectin
domain is also presented.
2. Materials and Methods
2.1 Site-directed mutagenesis of soluble rat recombinant GalNAc-T1
Rat GalNAc-T1 cDNA was obtained as outlined by Hagen et al. [32]. The plasmid,
pInsProA∆N42, containing cDNA for soluble, tagged, rat GalNAc-T1 was prepared by deleting
the coding sequence for the cytoplasmic tail and the transmembrane domain from
full-length GalNAc-T1 cDNA, and by fusing cDNA for an insulin signal sequence and a
Protein A-IgG binding domain to the resulting 5’-end of the truncated GalNAc-T1 cDNA
as described previously [33]. Site-directed mutagenesis was performed on pInsProA∆N42
using the LA PCRTM in vitro mutagenesis kit using the primers listed below [33]. Nucleotides
expressed in bold face are altered nucleotides to introduce mutations to GalNAc-T1. DC130,
AATCAGAAATAGTGACGAGG; DC85, TTCTAATTTATTTGTTGGCA; DC45,
ACATGCTGCTAGGTTAATTT; DC1, TCTCATTATATTTCTGGAAGGG; DC3,
TCTCAGAATATTTATGGAAGGG; DC9, ATTTCAAAGAAGCCACTGCT; DC12,
AAGTCACTGCTGGGACC; C442A, CTAGAGCTTGATTTGTTTCC; C459A,
ACCATGAGCATTAAAAATTC; C482A, GTCCAAAGCAAGGTCATCTG; C497A,
GTGGTGGGCTTTGAGCATGG; C523A, TTATCCAGGGCCTGGTTACT; C540A,
TTCCAGTGGCGTCTCTGATG; D444A, TTCTAGCCATGTTAGCTAGAC; G455Q,
AAATTTGAACCTTTTCATTCTCT; F457A, ATACCATGACAATTAGCAATTCC; N465A,
AGAGAAAACCTGAGCGCCTC; Q466A, AGAGAAAACCGCATTGCCTC; F468A,
TGGCAGTGTAAGAGGCAACC; F468Y, TGGCAGTGTAAGAGTAAACC; F468W,
TGGCAGTGTAAGACCAAACC; D484A, ACGGCCAAACAAAGGTCATC; D525A,
GCTTTAGCCAGGCACTGGTT; MEcoT22I GNT1, GAATGCATCAAATGTGAAGA; 3.1R,
TAGAAGGCACAGTCGAGG.
2.2 Expression of P-∆N42 and mutant P-∆N42 in COS7 cells
The fusion protein (P-∆N42), containing a Protein A-IgG binding domain at the N-terminus,
and mutant P-∆N42 were expressed in COS7 cells and purified from the conditioned medium
as described previously [33]. SDS-PAGE and Western blotting of the recombinant molecules
were also carried out as described [33]. The protein bands on the immunoblots were scanned
and quantitated with a Luminoimage Analyzer LAS-1000 PLUS (Fujifilm). The activities of
P-∆N42 and mutant P-∆N42 were determined as described below and the activity levels were
corrected for the enzyme protein concentration in the medium.
2.3 GalNAc-transferase assay
GalNAc-transferase assays using apomucin and peptide acceptors as acceptors were carried
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out as described in [33] and [34], respectively. Kinetic analysis of P-∆N42 and its mutants were
carried out as described previously [33].
2.4 Preparation and expression of H-∆N32 and H-∆N32∆C130
A truncated form of rat GalNAc-T1, lacking the 32 N-terminal amino acid residues,
including the cytoplasmic tail and the transmembrane domain, was amplified by PCR,
using full-length GalNAc-T1 cDNA, cloned in pcDNA3.1, as a template. For this reaction,
the primer set, MEcoT22I-GNT1 and 3.1R, was used. A truncated form of rat GalNAc-T1,
lacking the 32 N-terminal (including the cytoplasmic and transmembrane domains) and the
130 C-terminal amino acid residues (including the (QXW)3 repeats), was amplified by PCR
using the primer set, MEcoT22I-GNT1 and DC130. PCR was carried out with KOD dash
DNA polymerase for 30 cycles of 96℃ for 30 sec, 50℃ for 30 sec, and 72℃ for 2 min. The
PCR products were purified and ligated into the pGEM-T easy (Promega), to generate plas-
mids containing the truncated GalNAc-T1 cDNAs (p∆N32 and p∆N32∆C130). A synthetic
linker fragment, encoding His and HA tags, (HHHHHHGGYPYDVPDYAGG) with BamHI
and EcoRI restriction sites at the 5’- and 3’-ends, respectively, was inserted into the BamHI-
EcoRI sites of pAcGP67A (a baculovirus transfer vector) to produce the vector, pAcGP67A-
His/HA. pAcGP67A-His/HA contains His and HA tag sequences, downstream of a secretion
signal sequence and a signal peptide cleavage site, such that the in-frame ligation of a cDNA
encoding a protein of interest leads to the production of a secreted protein with a His and an HA
tag at the N-terminus. p∆N32 and p∆N32∆C130 were digested with EcoT22I, and the coding
sequences for ∆N32 and ∆N32∆C130 were subcloned into the PstI sites of pAcGP67A-His/HA,
generating the plasmids pAcGP67A-His/HA/∆N32 and pAcGP67A-His/HA/∆N32∆C130, for
expression of secreted, truncated rat GalNAc-T1 fused to His and HA tags (H-∆N32 and H-
∆N32∆C130). Sf9 cells were grown at 27℃ in TMN-FH medium (Pharmingen) containing 10
％ fetal calf serum. Co-transfection of Sf9 cells, with the plasmid (pAcGP67A-His/HA/∆N32
or pAcGP67A-His/HA/∆N32∆C130) and Baculo-GoldTM DNA (Pharmingen), was performed
according to the manufacture’s specifications. Briefly, 0.4 µg of pAcGP67A-His/HA/∆N32 or
pAcGP67A-His/HA/∆N32∆C130 was mixed with 0.1 µg of Baculo-GoldTM DNA and then co-
transfected into Sf9 cells in 24-well plates. Five days after transfection, recombinant viruses
were collected from the culture medium. To prepare large virus stocks, the recombinant viruses
were inoculated in Sf9 cells with multiplicity of infection (MOI) of 0.01, and the culture media
were harvested after 3–5 days. For the expression of H-∆N32 and H-∆N32∆C130, recombinant
viruses were inoculated into Sf9 cells with a MOI of 5. After 3–5 days, the culture medium
containing the recombinant proteins was collected.
2.5 Binding assay with UDP-hexanolamine-agarose and apomucin-Sepharose
To assess binding activity with UDP, conditioned medium containing either H-∆N32 or
H-∆N32∆C130 was mixed with 20 µl of UDP-hexanolamine-agarose, in 600 µl of Buffer A
(25mM imidazole-HCl buffer, pH 7.2, containing 20mM MnCl2 and 100mM NaCl), and in-
cubated by rocking, at 4℃, for 2 hours. Following centrifugation at 2,500 rpm for 5 min, the
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supernatant was recovered and the resin was washed with Buffer A. The supernatants were
combined and referred to as the unbound fraction. The resin was washed twice with Buffer
B (25mM imidazole-HCl buffer, pH 7.2, containing 20mM MnCl2, 1M NaCl, and 0.1％ Tri-
ton X-100). Adsorbed proteins were eluted by washing the resin twice with Buffer C (25mM
imidazole-HCl buffer, pH 7.2, containing 1MNaCl and 50mMEDTA). Finally, strongly bound
proteins that were not eluted with EDTA, were released by boiling the resin in SDS-PAGE sam-
ple buffer. Mutant GalNAc-T1 proteins in each fraction were immunoprecipitated by incubating
with an anti-His6 tag antibody (Invitrogen) and Protein-G Sepharose. The precipitated proteins
were analyzed by SDS-PAGE, followed by Western blotting using PVDF membranes. The re-
combinant proteins on the membrane were probed with anti-HA 3F10 antibodies conjugated
with peroxidase (Roche) and visualized using the ECL Western blotting analysis system from
Amersham Pharmacia Biotech. In the binding experiments with apomucin-Sepharose, samples
containing either H-∆N32 or H-∆N32∆C130 were fractionated in a similar fashion with the
exception that Buffers A and B contained 0.25mM UDP. Proteins recovered from each fraction
were analyzed by SDS-PAGE followed by Western blotting and detection by ECL.
3. Results
3.1 Effect of deletion of the (QXW)3 repeats on GalNAc-T1 activity
To investigate the role of the GalNAc-T1 (QXW)3 repeats in catalysis, I prepared three dele-
tion mutants, P-∆N42∆C45, P-∆N42∆C85, and P-∆N42∆C130, in which the γ repeat unit, the
γ and β repeat units, and the entire (QXW)3 repeat domain were deleted, respectively (Fig. 1).
The mutant P-∆N42 molecules, as well as intact P-∆N42 were subsequently expressed in COS7
cells, the secreted fusion proteins were isolated from the culture medium, and their activities
were determined, using deglycosylated bovine submaxillary mucin (apomucin) as acceptor.
Previous work has demonstrated that bovine submaxillary apomucin is an efficient substrate
of GalNAc-T1 [35]. The molecule is characterized by a high content of serine, threonine,
and proline residues and as a consequence contains a large number of putative sites for O-
glycosylation [36–39]. Chemical analysis of the apomucin preparation used in this investigation
failed to detect any remaining GalNAc, indicating that virtually all the GalNAc residues were
released from the mucin molecule. The secreted fusion proteins were quantified by Western
blotting, as described under Materials and Methods. Their enzymatic activities were corrected
for the levels of enzyme protein, and expressed as relative to that of P-∆N42 such that the effect
of each mutation, on the enzymatic activity, could be evaluated. Western blotting of the COS7
cells produced proteins showed that their molecular weights correlated well with the degree of
the truncation, and also that the expression levels of all the mutant proteins were significantly
decreased, as compared to P-∆N42 (Fig. 1). Moreover, the enzymatic activities of the mu-
tant proteins were reduced to almost background level. This suggests that the (QXW)3 repeats
are important for stable expression and/or secretion, as well as for the enzymatic activity of
GalNAc-T1.
To assess the importance of the C-terminal sequence for the activity of GalNAc-T1, the
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Fig. 1 Expression and enzymatic activity of the (QXW)3 deletion mutants
A) Schematic representation of wild type and mutant GalNAc-T1. B) Enzymatic activity of mutant
GalNAc-T1 enzymes. The mutant enzymes were expressed in COS7 cells and the secreted recombinant
proteins were recovered from the culture medium. The amount of the secreted protein was determined
by Western blotting followed by densitometric scanning of the blot (lower panel). The enzymatic activity
secreted in the medium was determined using apomucin as acceptor, corrected for the amount of the en-
zyme protein in the medium, and expressed as activity relative to that of P-∆N42. Mutant enzymes, solid
bars; P-∆N42, hatched bar
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deletion mutants P-∆N42∆C1, P-∆N42∆C3, P-∆N42∆C9, and P-∆N42∆C12 were generated
(Fig. 2A). As shown in Fig. 2B, P-∆N42∆C1 and P-∆N42∆C3 were fully active, while the
activity of P-∆N42∆C9 was about 50％ of that of P-∆N42. Interestingly, the deletion of 12
amino acid residues from the C-terminus (P-∆N42∆C12) resulted in complete inactivation of P-
∆N42. The reason for the inactivation of this mutant enzyme is not clear, but it may be related to
the loss of Trp548. This tryptophan residue is conserved in ricin and in all GalNAc-transferases
cloned to date. Moreover, it is reported to be essential for the formation of the hydrophobic core
in the globular lectin domain [25–27]. The results from the C-terminal deletion experiments
suggest that a properly folded (QXW)3 repeat domain is essential for the enzymatic activity of
Fig. 2 Enzymatic activity of C-terminal deletion mutant enzymes
A) C-Terminal amino acid sequence of GalNAc-T1. The C-terminus of each deletion mutant is indicated
by an arrow. B) Enzymatic activity of the C-terminal deletion mutants. Enzyme assay and Western
blotting of the expressed mutants were carried out as described in the legend to Fig. 1. Mutant enzymes,
solid bars; P-∆N42, hatched bar
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GalNAc-T1.
3.2 The disulfide bonds in the (QXW)3 repeats are essential for the activity
The (QXW)3 repeats are predicted to contain three disulfide bonds (Cys442-Cys459, Cys482-
Cys497, and Cys523-Cys540), i.e., one disulfide bridge in each repeating unit (Fig. 3A) [28]. It
is likely that these disulfide bonds stabilize the globular conformation of each unit. To examine
whether disruption of the disulfide bonds in the repeats affects the enzymatic activity, I prepared
mutant constructs for each cysteine residue in the (QXW)3 repeat domain. Fig. 3B shows
that all the mutant proteins generated were completely inactive. Moreover, their expression
levels were significantly decreased. Consistent with the results from my constructs with deleted
(QXW)3 repeats (see above), this again indicates that the integrity of this domain is important
Fig. 3 Enzymatic activity of enzymes with mutated cysteine residues in the (QXW)3 repeats
A) Positions of the disulfide bonds in the GalNAc-T1 (QXW)3 repeats. B) Enzymatic activity of the
mutant enzymes. Enzyme assays and Western blotting of mutant proteins were carried out as described in
the legend to Fig. 1. Mutant enzymes, solid bars; P-∆N42, hatched bar
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for GalNAc-T1 activity.
3.3 Binding of the C-terminal deletion mutant to UDP-hexanolamine-agarose and
apomucin-Sepharose
The inactivation of P-∆N42, caused by truncation of the (QXW)3 repeats or disruption of
the disulfide bonds in the (QXW)3 repeats, may result either from a conformational change in
the entire enzyme molecule, or from malfolding of the C-terminal repeat domain. To evalu-
ate the effects of deletion of the C-terminal domain, I compared the UDP-binding activities of
the GalNAc-T1 mutants. As reported previously, GalNAc-T1 primarily recognizes the UDP
portion of UDP-GalNAc [3,40]. In fact, UDP-affinity chromatography has been used success-
fully for purification of GalNAc-transferases [41,42]. To investigate the capacity of the mutant
enzymes for nucleotide sugar binding, I generated the GalNAc-T1 mutant enzymes, H-∆N32
and H-∆N32∆C130 that, instead of a large Protein A-IgG binding domain, have a His tag
and a haemagglutinin (HA) epitope tag (19 amino acid residues in total) fused to N-terminus
(Fig. 4A). This was done since my preliminary binding experiments demonstrated that enzy-
matically active P-∆N42 failed to bind to UDP-hexanolamine-agarose, while P-∆N42∆C130
retained capacity for binding (data not shown). I considered it possible that the large Pro-
tein A-IgG binding domain (∼ 30 kDa) in P-∆N42 (Fig. 1A) could sterically interfere with
the binding to UDP immobilized on agarose. Deletion of the entire C-terminal lectin do-
main might mitigate this steric hindrance, thereby making retention of P-∆N42∆C130 on the
UDP-hexanolamine-agarose possible. The His/HA-tag fusion constructs were expressed as se-
creted proteins in insect cells, using the baculovirus expression system. The secreted molecules
were purified with Ni+-chelating chromatography and assayed for enzymatic activity. While
H-∆N32 was enzymatically active at levels similar to P-∆N42, H-∆N32∆C130 was inactive.
This was also the case for P-∆N42∆C130. Culture media containing either H-∆N32 or H-
∆N32∆C130 were mixed with UDP-hexanolamine-agarose. Following incubation, the sus-
pension was centrifuged to obtain fractions containing UDP-hexanolamine-unbound (the su-
pernatant) and UDP-hexanolamine-bound (the resin) material. The UDP-hexanolamine-bound
fraction was washed with the buffer containing 1M NaCl and 0.1％ Triton X-100. The ad-
sorbed proteins on the resin were then eluted by chelating Mn2+, a metal ion essential for donor
substrate binding, with EDTA. H-∆N32 or H-∆N32∆C130 recovered in the bound and unbound
fractions was immunoprecipitated with an anti-His6 tag antibody, subjected to SDS-PAGE, and
analyzed by Western blotting, using a peroxidase conjugated anti-HA-antibody. Adsorbed pro-
teins not eluted with EDTA were released by boiling the resin in the SDS-PAGE sample buffer.
In contrast to the results from the constructs containing a Protein A-IgG binding domain, both
H-∆N32 and H-∆N32∆C130 were capable of binding to UDP-hexanolamine-agarose (Fig. 4B).
H-∆N32 appeared to bind stronger than H-∆N32∆C130. Still, small amounts of the recombi-
nant proteins were also found in the unbound fractions. This may represent denatured proteins,
since no enzymatic activity was detected in these fractions (data not shown). The specificity
of the interaction(s) of H-∆N32 and H-∆N32∆C130 with UDP-hexanolamine-agarose was in-
vestigated by preincubating both molecules with either 2mM UDP or 50mM GDP, before
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Fig. 4 Binding of H-∆N32 and H-∆N32∆C130 to UDP-hexanolamine-agarose and apomucin-Sepharose
A) Schematic representation of the His/HA tagged recombinant molecules used for the binding ex-
periments. B) Binding of the His/HA tagged proteins to UDP-hexanolamine-agarose. H-∆N32 and
H-∆N32∆C130 were expressed in Sf9 cells, and the recombinant proteins in the conditioned medium
were fractionated as described under Materials and Methods. In the control experiments, H-∆N32
and H-∆N32∆C130 were incubated with either 2mM UDP or 50mM GDP before mixing with UDP-
hexanolamine-agarose. The His/HA tagged proteins recovered in the bound and unbound fractions were
immunoprecipitated with an anti-His6 tag antibody. The immunoprecipitated proteins were separated on
SDS-PAGE and blotted to a PVDFmembrane. The His/HA tagged proteins on the membrane were probed
with an anti-HA-antibody (3F10) conjugated to peroxidase and detected with an ECL Western blotting
analysis system. C) Binding of the His/HA tagged proteins to apomucin-Sepharose. Binding assays were
carried out as described in B) except that apomucin-Sepharose was used instead of UDP-hexanolamine-
agarose and that the buffers contained 0.25mMUDP. Control experiments were carried out in the absence
of UDP.
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adding the resin. Figure 4B shows that while GDP had no effect (data not shown), UDP com-
pletely blocked the binding of both molecules to UDP-hexanolamine-agarose, suggesting that
the binding of both H-∆N32 and H-∆N32∆C130 is specific for the UDP moiety on the resin.
Taken together, these results suggest that the C-terminal deletion mutant proteins retain the
capacity for UDP-binding, although they lack enzymatic activity.
Next, I compared the acceptor-binding activity of H-∆N32 and H-∆N32∆C130. Medium
containing either recombinant protein was mixed with apomucin-Sepharose. The apomucin-
resins were treated as described above for UDP-hexanolamine-agarose, except that the buffers
contained 0.25mM UDP. H-∆N32 bound quite avidly to apomucin (Fig. 4C). Most of H-∆N32
added to the apomucin matrix was recovered in the EDTA and SDS-PAGE sample buffer elu-
ates. H-∆N32 recovered in the unbound fraction was enzymatically inactive, suggesting that all
enzymatically active molecules bound to the matrix. H-∆N32∆C130 also bound to apomucin-
Sepharose, although with the significantly lower affinity. Bound H-∆N32∆C130 was for the
most part recovered in the EDTA eluate and in the wash fraction. None of the protein was
recovered in the SDS-PAGE sample buffer eluate. It should be noted that both H-∆N32 and
H-∆N32∆C130 required UDP for binding to apomucin. Without UDP, both failed to bind and
were recovered exclusively in the unbound fractions (Fig. 4C). It appears likely that the binding
of UDP produces a change in the conformation of the catalytic domain that allows binding to
apomucin. The lectin domain appears not to be involved in this conformational change.
Together with the experiments described above, these results suggest that H-∆N32∆C130,
though enzymatically inactive, retains the capacity to bind to both UDP and apomucin. Conse-
quently, deletion of the lectin domain from GalNAc-T1 apparently does not cause any change
in the overall conformation of the catalytic domain of the enzyme. The data also indicate that
the catalytic domain in itself may be sufficient for binding to the substrates and that the inter-
action of the enzyme with the acceptor substrate (apomucin) was based on the protein-protein
interaction, since the mutant, H-∆N32∆C130, in which the entire (QXW)3 domain is deleted,
was capable of binding with apomucin. The reason for the weaker binding of H-∆N32∆C130
to apomucin and UDP, as compared to H-∆N32, is not clear, but it may be related to the specific
interactions between the catalytic and lectin domains of the molecule, as described in Discus-
sion.
3.4 Characterization of the (QXW)3 mutants
Figure 5 shows a comparison of the amino acid sequences of ricin and GalNAc-T1 (QXW)3
repeats. X-Ray crystallography studies of the ricin (QXW)3 repeats have demonstrated that
they contain two independent active domains (1α and 2γ), both of which are capable of binding
lactose [25,26]. In these domains, the haptenic monosaccharide galactose, is located in a cleft,
in which conserved hydrophobic residues contribute to form a compact hydrophobic core. In
the ricin 1α domain (Fig. 5A), Asp22, Asn46, Gln47, Gln35, and Trp37 (Asp234, Asn255, Gln256,
Ile246, and Tyr248 in the 2γ domain) are involved in binding with galactose. Trp49 (Trp258 in
the 2γ domain) is an essential aromatic residue for the hydrophobic core of the globular do-
main [25,26]. Although the sequence identities are modest between the (QXW)3 repeats of
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Fig. 5 Amino acid alignment of the (QXW)3 repeats in ricin and GalNAc-T1
Putative amino acids involved in carbohydrate binding are marked by dots and amino acids required for
formation of the hydrophobic core are denoted by triangles. Amino acid residues discussed in the text
are indicated by arrows and numbered from the N-terminus of the proteins. Segments with low similarity
are omitted. A) Amino acid sequence of the 1α and the 2γ repeats in the ricin B-chain. B) Amino acid
sequence of the GalNAc-T1 (QXW)3 repeat domain.
GalNAc-T1 and ricin, threading methods predict both molecules to have similar globular con-
formations [24,28]. Judging from the structure of ricin, the α repeat, of the three repeats in
GalNAc-T1, is most likely to have sugar-binding activity, since this unit contains all amino
acid residues required for the sugar binding and the hydrophobic core formation, with the
exception of Gly455 (Fig. 5B). I investigated the role of the GalNAc-T1 α repeat unit using
site-directed mutagenesis of amino acids corresponding to residues identified as being involved
in ligand binding in ricin. I mutated the possible sugar-binding sites, Asp444, Phe457, Asn465,
and Gln466 of P-∆N42, into alanine. I also mutated Gly455 into glutamine such that the mu-
tated α repeat unit would have sugar-binding sites identical to those in ricin. Phe468, a residue
putatively essential for the hydrophobic core structure, was also mutated. Three different mu-
tations (F468W, F468Y, and F468A) were generated at this site. F468W and F468Y represent
conservative amino acid replacements, while F468A is expected to result in disruption of the
hydrophobic core due to loss of the aromatic ring and also to cause a conformational change in
the repeat domain. All mutant sequences were expressed in COS7 cells and the activities of the
mutant enzymes were determined using apomucin or the synthetic peptide, PPDAATAAPL, as
acceptors. PPDAATAAPL, which represents a modification of an O-glycosylated sequence in
erythropoietin, contains a single glycosylation site. The peptide is a very efficient acceptor for
GalNAc-T1, exhibiting Km value of approximately 0.20mM [3].
The enzymes with single point mutations at the putative sugar binding sites (Fig. 6A) were
secreted into the medium, to the same extent as P-∆N42, suggesting that the mutated sites had
little impact on the secretion and stability of the molecules.
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Fig. 6 Activity of enzymes containing mutations in the (QXW)3 repeats
Enzyme activity measurements and Western blotting of mutant proteins were carried out as described in
the legend to Fig. 1. Solid and hatched bars indicate enzymatic activity determined using apomucin and
PPDAATAAPL as acceptor, respectively. A) Enzymes containing mutations at the putative sugar binding
sites. B) Enzymes containing mutations at the Asp residues. C) Enzymes containing mutations of the
putative amino acid required for formation the hydrophobic core.
Moreover, the activity when using the peptide PPDAATAAPL, was essentially unaffected.
On the other hand, the relative activities of the mutant enzymes when using apomucin as ac-
ceptor, were significantly decreased, compared to the parent molecules. Asp444 appears most
important among the putative sugar binding sites in the α repeat domain, since apomucin gly-
cosylation by D444A was most severely impaired, among the mutant enzymes. The aspartate
residues in the β and γ repeats, Asp484 and Asp525, corresponding to Asp444 in the α repeat, are
also conserved (Fig. 5) suggesting a possible role for these residues in the binding to apomucin.
To investigate the functional importance of the β and γ repeats, I generated two additional
mutants, D484A and D525A. The measured relative activity of D484A toward apomucin was
significantly decreased, although not to the level of D444A (Fig. 6B). On the other hand, similar
to D444A, the activity of D484A using the acceptor peptide, PPDAATAAPL, was essentially
unaffected. In contrast to D444A and D484A, the activity of D525A was unchanged with both
substrates (Fig. 6B). This suggests that the β repeat, as well as the α repeat, is important for
glycosylation of substrates with multiple acceptor sites, but the γ repeat may not be. To con-
firm the role of individual repeat units in apomucin glycosylation, I generated double and triple
mutant enzyme, D444A/D484A and D444A/D484A/D525A. These molecules contain muta-
tions at the putative sugar-binding aspartic acid residues in the α and β repeats and in all three
repeats, respectively. As shown in Fig. 6B, the activity of D444A/D484A with apomucin was
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low as that of D444A/D484A/D525A. The activity of the both mutants, at 20％ the activity of
P-∆N42, were significantly lower than that of D444A. Moreover, the mutant enzymes glycosy-
lated the peptide acceptor as efficiently as the wild type enzyme. These results suggest that, at
least, two of the (QXW)3 repeats interact cooperatively with acceptors with multiple acceptor
sites.
Taken together, the data indicate that the observed partial decrease in apomucin O-
glycosylation by the mutant enzymes may be attributed to biased O-glycosylation of the ac-
ceptor sites in apomucin, rather to an overall decrease in glycosylation efficiency, since the
peptide acceptor PPDAATAAPL was glycosylated at similar efficiency by both the wild type
and mutant enzymes; i.e., it appears that the mutant enzymes are capable of glycosylating some
sites in apomucin as efficiently as the wild type, while other sites are glycosylated at a slower
rate or not at all.
Mutation at Phe468 strongly influenced both the expression level and activity of the mu-
tant enzymes (Fig. 6C). In contrast to the enzymes with conservative amino acid replacements
(F468W and F468Y), the expression of F468A was significantly decreased, and its enzymatic
activity, using either acceptor was reduced to almost background level. The presence of an aro-
matic group appears to be essential at position 468, as predicted by its role in the hydrophobic
core formation of the lectin domain [28]. The inactivation of GalNAc-T1 resulting from site-
directed mutagenesis as well as the C-terminal deletions is likely caused by conformational
changes in the (QXW)3 repeats.
To evaluate the potential involvement of the (QXW)3 repeats in catalysis, kinetic analysis
was carried out on the mutant enzymes (Table 1). All the mutant enzymes generated Km val-
ues for UDP-GalNAc that were almost identical to that of P-∆N42, in spite of the fact that the
mutations were located at potential sugar-binding sites in the repeats. The sugar-binding ac-
tivity of the (QXW)3 repeats appears, therefore, to be involved in acceptor recognition, rather
Table 1 Kinetic analysis of the (QXW)3 mutants
UDP-GalNAc apomucin
Km (mM) -fold Km (mg/ml) -fold
P-∆N42 5.1±0.8 1.00 4.7±0.01 1.00
D444A 5.1±0.6 1.00 39.2±7.3 8.34
G455Q 4.0±0.1 0.78 16.2±3.8 3.45
F457A 5.4±0.2 1.06 8.2±1.5 1.74
N465A 3.6±0.5 0.71 6.5±0.4 1.38
Q466A 6.1±0.1 1.20 15.5±0.1 3.30
D484A 4.1±0.4 0.8 17.1±0.4 3.6
D525A 4.3±0.2 0.9 4.6±0.4 1.0
D444A/D484A 5.9±0.5 1.2 93.0±9.7 19.8
D444A/D484A/D525A 4.4±0.9 0.9 106.1±2.8 22.6
Km for UDP-GalNAc and apomucin was determined as described under Materials
and Methods. Values are the average of three distinct reactions.
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than in the binding to the sugar donor. Consistent with this, the affinity of the mutant enzymes
for apomucin, was significantly decreased (Table 1). There was a clear correlation between
the affinity for apomucin and the acceptor activity of this protein (Table 1 and Fig. 6A). Of
the mutant enzymes tested, D444A, D444A/D484A, and D444A/D484A/D525A showed the
marked increase (approximately 8- and 23-fold, respectively) in their Km values for apomucin.
The (QXW)3 repeats, therefore, appear to be involved in the binding of acceptors with multiple
glycosylation sites. It appears possible that the lectin domain promotes the glycosylation of
polypeptides with multiple acceptor sites by recognizing GalNAc residues at adjacent sites on
the acceptor. Since apomucin does not contain any detectable GalNAc residues, the lectin do-
main of the enzyme must interact with GalNAc residues transferred to apomucin in the course
of the reaction.
3.5 Each repeat in the lectin domain cooperatively interacts with GalNAc on the accep-
tor
In order to further investigate the role of the (QXW)3 repeats in the recognition of apomucin,
the influence of monosaccharides on the GalNAc-T1 activity was examined. In a previous re-
port, I demonstrated that micromolar concentrations of free GalNAc do not inhibit GalNAc-T1
catalyzed glycosylation [3]. However, a high concentration of GalNAc was recently shown
to inhibit GalNAc-T4, a follow-up type isozyme that requires the prior O-glycosylation of the
acceptor polypeptides [30]. To investigate if GalNAc-T1 was similarly affected by high sugar
concentrations, I studied the effect of 300mM monosaccharides on the activity of P-∆N42. In
reactions using apomucin as acceptor (Fig. 7A), GalNAc was a quite potent inhibitor. Approx-
imately 80％ of the GalNAc incorporation into apomucin was inhibited. By contrast, Gal, Glc,
GlcNAc, Man, and Fuc had no significant inhibitory activity. The inhibition of P-∆N42 by
GalNAc was concentration-dependent, generating an apparent Ki of 68mM (Fig. 8). This is
almost as efficient as the reported inhibition of GalNAc-T4 by this sugar (Ki = 50mM)[30]. In-
terestingly, the inhibitory effect of free GalNAc was entirely dependent on the type of acceptor
used. When PPDAATAAPL was used, there was no measurable inhibition by GalNAc (or any
of the other monsaccharides tested) (Fig. 7B). This indicates that GalNAc-T1 has two activities
that can be distinguished by the inhibition with free GalNAc, i.e. one activity is sensitive to
the inhibition, and the other is resistant. In my experiments, the former activity is represented
by the O-glycosylation of apomucin that contains multiple glycosylation sites, and the latter
by the single-acceptor site peptide. To confirm the involvement of the lectin domain in the
GalNAc sensitivity of GalNAc-T1, analogous experiments were carried out with the (QXW)3
mutants. As discussed above, these mutant enzymes display only moderate activity toward apo-
mucin (Fig. 6A, 6B, and Table 1). The glycosylation of apomucin was affected significantly
(Fig. 7A). Again, only GalNAc, of the monosaccharides tested, was effective. And, as ex-
pected, the GalNAc inhibition was correlated with the extent of mutations in the lectin domain
(Fig. 8). Of the single-point mutant enzymes, D444A exhibited the highest degree of resis-
tance to GalNAc inhibition. In analogy with P-∆N42, the inhibition of D444A by GalNAc was
concentration-dependent (Fig. 8), with Ki of 173mM. This is 2.5-fold higher than that (68mM)
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Fig. 7 Inhibition of enzymatic activity by free monosaccharides
The inhibitory activity of monosaccharides was determined using A) apomucin, B) PPDAATAAPL, and
C) GVVPTVVPG, as acceptors. The enzymatic activity of the recombinant proteins is expressed as
relative to the activity determined in the absence of added monosaccharides. Solid bars denote the activity
of P-∆N42, hatched and white bars that of the mutant enzymes D444A, and D444A/D484A/D525A,
respectively.
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of P-∆N42. D484Awas more resistant than D525A, while D525Awas almost as sensitive to the
GalNAc inhibition as the parent enzymes. I also observed an almost identical decrease in affin-
ity for GalNAc with D444A/D484A and D444A/D484A/D525A, which were more resistant to
inhibition than D444A. The very low affinity of D444A/D484A and D444A/D484A/D525A for
GalNAc made determination of an inhibition constant difficult. These mutant enzymes retained
70％ of its activity towards apomucin even in the presence of 300mM GalNAc (Figs. 7A and
8). By contrast, when assayed with the peptide PPDAATAAPL (Fig. 7B), no inhibition by
monosaccharides was observed for these mutant (Fig. 7B). I also investigated the inhibition
by GalNAc, using another single acceptor site peptide, GVVPTVVPG. This peptide is also an
efficient acceptor with a Km value of approximately 0.80mM. Again, the peptide was glyco-
sylated at the similar efficiency by both the parent and the mutant enzymes, and no significant
inhibition by GalNAc was observed (Fig. 7C).
Taken together, the data clearly suggest that the lectin domain of GalNAc-T1 is involved
in glycosylation of substrates with multiple acceptor sites such as apomucin. GalNAc-T1,
Fig. 8 Inhibition of enzymes containing mutations in the (QXW)3 repeat domain, with free GalNAc
The recombinant enzymes were expressed in COS7 cells and purified from the conditioned medium on
IgG-Sepharose. The enzymatic activity of the mutant proteins was assayed in the presence of increasing
concentrations of free GalNAc. Apomucin was used as acceptor. ■: P-∆N42,●: D444A, ▲: D484A,
◆: D525A,□: D444A/D484A, and○: D444A/D484A/D525A.
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appears to recognize GalNAc residues on the acceptor polypeptides that in situ may have been
transferred by GalNAc-T1 itself or another GalNAc-transferase. Moreover, the α and β repeats
in the lectin doman of GalNAc-T1 are capable of recognizing GalNAc, with the α repeat having
the higher affinity. These two repeat units in the lectin domain functions in a cooperative
manner in the recognition of GalNAc residues on acceptor polypeptides.
4. Discussion
This report demonstrates a measurable function for the (putative) lectin domain on GalNAc-
T1. I demonstrate that the (QXW)3 repeats of GalNAc-T1 are functional and that they have a
defined function in the glycosylation of substrates with multiple acceptor sites, such as apo-
mucin. Glycosylation of the synthetic peptides, PPDAATAAPL and GVVPTVVPG, was in-
dependent of the (QXW)3 repeats, as demonstrated by the efficient glycosylation of these pep-
tides by both the wild type and the mutant enzymes (Figs. 6 and 7). I have also demonstrated
that the function of the (QXW)3 repeats is related to carbohydrate recognition (Figs. 7 and 8).
Based on these observations, I hypothesize that GalNAc-T1 catalyzes two distinct reactions.
One is the initial O-glycosylation of unglycosylated polypeptide acceptors. This reaction is
independent of the (QXW)3 repeats and is not inhibitable by free GalNAc. Consequently, the
substrate specificity of this reaction would be determined predominantly by information in the
acceptor polypeptides, such as the primary and secondary structures [3,43]. The other reaction
is a follow-up glycosylation. This would be dependent on the lectin activity of the (QXW)3
repeats and would be inhibitable by GalNAc. The follow-up glycosylation would be signifi-
cantly influenced by the structure of the acceptor polypeptides and their degree of glycosyla-
tion [30,31,44–46]. The addition of β1,3Gal to GalNAc would inhibit the follow-up reaction,
since Gal is not recognized by the (QXW)3 repeats (Fig. 7). A similar binding specificity has
been observed for GalNAc-T4 [30,31]. Thus, it appears plausible that the presence of a disac-
charide, Galβ1,3GalNAc, at one potential O-glycosylation site may reduce O-glycosylation at
neighboring potential sites, on the same peptide [31,44].
Considering the possible role of the (QXW)3 repeats, a model for O-glycosylation of
polypeptides with multiple acceptor sites by GalNAc-T1 can be postulated (Fig 9). a) As
reported in a previous paper, the reaction is initiated by the binding of the enzyme to UDP-
GalNAc [3]. b) This binding brings about conformational changes in GalNAc-T1, enabling
it to bind to acceptor polypeptides. Requirement of UDP for the binding of H-∆N32 and
H-∆N32∆C130 with apomucin-Sepharose, as well as results from previous work is consis-
tent with this idea [3,35]. c) GalNAc-T1 then recognizes the acceptor polypeptide via the
protein-protein interaction, which was demonstrated by the binding of the lectin domain dele-
tion mutant, H-∆N32∆C130, to apomucin-Sepharose (Fig. 4C). d) The enzyme, then, transfers
GalNAc residues to the acceptor by the initial O-glycosylation activity. Following the initial
O-glycosylation of the acceptor, the glycosylated acceptor would be dissociated from the en-
zyme. This is essential for the recycling of the enzyme and for the subsequent glycosylation
of substrates. e) The glycosylated acceptor may, then, be recognized by the lectin domain of
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Fig. 9 A model for O-glycosylation by GalNAc-T1
a) Binding of the enzyme to UDP, b) conformational change in the catalytic domain, c) binding of accep-
tors, d) initial glycosylation, e) binding with GalNAc on the acceptor, f) followup glycosylation, and g)
inhibition by free GalNAc. A detailed explanation of this model is included in the Discussion.
GalNAc-T1 through protein-carbohydrate interaction. Concomitant protein-protein interaction
would make the binding between glycosylated acceptors and the enzyme more stable. The im-
portance of the carbohydrate-protein interaction is demonstrated by the reduced glycosylation
of apomucin by the mutants with alterations at the putative sugar-binding sites (Fig. 6A and
Table 1). f) The enzyme would transfer GalNAc to the glycosylated acceptor, i.e. function
as a follow-up enzyme. The addition of free GalNAc to the reaction mixture would interfere
with binding of the enzyme to glycosylated acceptors, causing inhibition of the follow-up O-
glycosylation. Consequently, it appears possible that the enzymatic activity remaining in the
presence of high concentration of GalNAc represents the initial O-glycosylation activity of
GalNAc-T1 (Figs. 7 and 8).
It is noteworthy that mutations causing conformational changes in the lectin domain com-
pletely ablated the enzymatic activity of GalNAc-T1, in spite of data suggesting that the lectin
domain is involved in follow-up glycosylation only. Moreover, the deleterious effects on the
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activity were observed by truncation of either of the three (QXW)3 repeats (Fig. 1) or by muta-
tion of the amino acid at the putative hydrophobic core of the lectin domain (Fig. 6). Follow-up
glycosylation is expected to occur at potential acceptor sites located at close proximity to the
initially glycosylated sites in the acceptor, since follow-up O-glycosylation can be assayed with
relatively short synthetic peptides [30,31,44,46,47]. Hence, it appears reasonable to assume in-
teraction between the catalytic and lectin domains of GalNAc-T1. This may be required to
bring the two domains close together to efficiently carry out follow-up glycosylation. Conse-
quently, mutations, which disrupt the lectin domain structure, could influence the conformation
of the catalytic domain, thereby inactivating both the initial and the follow-up activities of the
enzyme. The weaker binding of the C-terminal deletion mutant to UDP-hexanolamine-agarose
and apomucin-Sepharose is consistent with conformational changes in the catalytic domain of
the molecule (Fig. 4). By contrast, the enzymes with mutations at the putative sugar binding
sites of the lectin domain could retain the native conformation of both domains. They would
therefore, lose the follow-up activity, while their initial activity would be essentially unchanged.
Interactions between the catalytic domain and the (QXW)3 repeats have been demonstrated in
the streptomyces olvaceovirids E-86 β-xylanase [48,49]. The interaction keeps both domains
close together, thereby making it possible to hydrolyze insoluble xylan with the help of the
lectin domain, in spite of the fact that this domain is not directly involved in catalysis [48–
51]. Similarly, the (QXW)3 repeats in GalNAc-T1 may play an auxiliary role in follow-up
glycosylation in coordination with the catalytic domain. The lectin domain of GalNAc-T1 is
not directly involved in the catalysis but it is essential for presenting the glycosylated acceptor
polypeptides to the catalytic domain.
This study produced new information on the structure-function relationship of the GalNAc-
T1 (QXW)3 repeats. I have demonstrated that the amino acid residues, at potential sugar bind-
ing sites (Asp444, Gly455, Phe457, Asn465, and Gln466) and at the hydrophobic core (Phe468), in
the α repeat, are important for the lectin function of this domain (Fig. 6). In particular, I found
that Asp444 was an important site for sugar recognition, as evidenced by the low affinity of
D444A for apomucin (Table 1) and by the decreased sensitivity of an enzyme carrying this mu-
tation, to GalNAc inhibition (Fig. 7). Interestingly, G455Q, in which glutamine is substituted
for Gly455, so as to introduce the ricin-like Gal-binding site into the α repeat of GalNAc-T1,
did not confer detectable Gal-binding activity to the mutant enzyme (unpublished data). In-
stead, this enzyme exhibited a reduced reactivity towards apomucin similar to the other mutant
enzymes. This suggests that the (QXW)3 repeats of GalNAc-T1 are conformationally different
from those of ricin, in spite of the fact that both lectin domains are supposed to originate from
a common ancestral Gal-binding protein [24,52]. The exact role of Gly455 in GalNAc-T1 is not
clear, but the reduced activity of the mutant enzyme could be the result of a local conforma-
tional change in the α repeat. The bulky, polar side chain of glutamine, as compared to glycine,
may restrict the flexibility of the polypeptide chain at position 455.
My results indicated that a predominant involvement of the α and β repeats in GalNAc
recognition during glycosylation of apomucin. The α repeat is shown to have higher affinity
for GalNAc than the β repeat, while no measurable GalNAc-binding activity was observed for
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the γ repeat. The sugar binding activity of all three repeat units correlated well with the location
of the putative sugar-binding residues, as deduced from sequence comparisons of the GalNAc-
T1 lectin domains to the ricin B-chain. Of the three repeat units in GalNAc-T1, the putative
sugar-binding amino acid residues in the α repeat, Asp444, Phe457, Asn465, and Gln466, show
the highest degree of conservation (with the ricin B-chain) [24,28]. The β repeat unit is sec-
ond in terms of conservation of putative sugar-binding sites. This repeat unit contains Asp484,
Asn503, and Gln504, corresponding to Asp444, Asn465, and Gln466 in the α repeat, but there
is a substitution (in the β repeat) at the site corresponding to Phe457 in the a repeat. Phe457
corresponding to Trp37 in ricin B-chain, a residue that makes a stacking interaction with galac-
tose [25,26]. The γ repeat also does not contain an aromatic residue at the site corresponding
to Phe457 in the α repeat. In addition, the γ repeat has an alteration at the site corresponding to
Asn465 in the α repeat. In ricin, the corresponding asparagines is involved in direct hydrogen
binding with galactose [25,26]. These considerations suggest a ranking of the sugar-binding
activities of the three repeat units in the following order: α > β > γ. Although no measurable
sugar-binding activity was detected for the γ repeat in this study, more sensitive methods may
yet reveal some capacity for GalNAc-binding in this unit. It is also possible that the γ repeat is
involved in binding of sugars other than GalNAc.
I found that two of the repeat units in the lectin domain of GalNAc-T1 are functional in
recognizing GalNAc. This indicates that the lectin domain of GalNAc-T1 is capable of at
least divalent interactions with glycosylated ligands. Lectins often contain contiguous modules
with multimeric complexes of two or more non-covalently linked modules [53,54]. Although
the binding affinity of an individual module may be low, strong binding can still be achieved,
through the interaction of multiple modules with ligand. Mucins are putative in vivo ligands
for the GalNAc transferases that are characterized by the presence of numerous carbohydrate
chains. Hence, it is likely that the multitude of GalNAc residues transferred to the core polypep-
tide during the glycosylation of mucins make multivalent interactions with the GalNAc trans-
ferase lectin domains possible. Although the binding of the individual repeat units in the lectin
domain may be weak, as represented by the requirement of a high concentration of GalNAc to
inhibit the apomucin glycosylation, the overall binding affinity between the GalNAc transferase
enzyme and the mucin acceptor is expected to be high enough to tether partially glycosylated
mucin molecules and carry out follow-up glycosylation.
The results presented in this report demonstrate the functional importance of the (QXW)3
repeats. The data show that this domain in fact is a functioning lectin on GalNAc-T1, at least
under the in vitro conditions tested. This led to the conclusion that GalNAc-T1, in addition to
glycosylating unmodified polypeptides in vivo, may also specifically recognize and glycosylate
partially glycosylated acceptors, i.e. it may also function as a “follow-up” enzyme. The results
generated in this study also provide new information about the substrate specificity of GalNAc-
T1. Although acceptor specificities of the GalNAc-transferases, has been studied quite exten-
sively, a specific consensus sequence has not been identified for any enzyme [3,55]. Instead,
GalNAc-T1 is regarded as a multi-substrate enzyme with broad acceptor specificity. Still, the
sequence context surrounding glycosylated serine and threonine residues is known to be impor-
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tant. Certain residues, at certain positions, in the vicinity of the acceptor amino acid are known
to promote glycosylation, while other residues are known to be refractory. Based on this infor-
mation, computer-based algorithms have been generated capable of predicting O-glycosylation,
with an accuracy of approximately 80％ [55,56]. The difficulty in exactly defining the substrate
specificity may in part be ascribed to the multiple functions of GalNAc-transferases, as demon-
strated by the two activities of GalNAc-T1. Discrimination between these two activities could
lead to a more in-depth understanding of the molecular mechanism of this enzyme. By intro-
ducing multiple mutations in the (QXW)3 repeats, I are currently preparing novel recombinant
enzymes that retain only the initial O-glycosylation activity. More detailed structural infor-
mation on the lectin domain would open the possibility of designing novel enzymes with the
altered (follow-up) substrate specificity.
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Footnotes
Abbrevations: EDTA, ethylenediaminetetraacetic acid; GalNAc, N-acetylgalactosamine;
GalNAc-transferase, UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase; GT1, gly-
cosyltransferase 1; HA, haemagglutinin; MOI, multiplicity of infection; PCR, polymerase
chain reaction; PVDF, polyvinilidene difluoride; UDP, uridine diphosphate; SDS-PAGE, SDS-
polyacrylamide gel electrophoresis.
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糖タンパク質のムチン型糖鎖生合成開始反応を触媒する UDP-GalNAc: polypeptide N-acetylgalactosaminyl-
transferase (GalNAc-T)は，タンパク質中のセリンおよびトレオニン残基のヒドロキシル基に GalNAcを転移













らに，ドメイン中の3つのリピートが α> β> γの順の強さで糖結合活性を持つこと，および αリピート中
の Asp444がレクチン様活性に最も重要な残基であることも見いだした．以上の結果は，GalNAc-T1のレク
チン様ドメインの GalNAc認識機構が follow-up活性によるアクセプターへの GalNAcの付加反応に必須で
あることを示している．
キーワード：ムチン型 O-グリコシレーション，GalNAc転移酵素，レクチン様ドメイン，構造活性相関，部
位特異的変異
